Stage
Grant - II | AliveTotal Raised
$150KLast Raised
$150K | 6 yrs agoExpert Collections containing RespiDx
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
RespiDx is included in 2 Expert Collections, including Medical Devices.
Medical Devices
8,082 items
Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.
Health IT
7,900 items
RespiDx Patents
RespiDx has filed 1 patent.
Application Date | Grant Date | Title | Related Topics | Status |
---|---|---|---|---|
1/28/2016 | Intensive care medicine, Respiratory therapy, Respiratory physiology, Attachment theory, Medical signs | Application |
Application Date | 1/28/2016 |
---|---|
Grant Date | |
Title | |
Related Topics | Intensive care medicine, Respiratory therapy, Respiratory physiology, Attachment theory, Medical signs |
Status | Application |
Latest RespiDx News
Mar 29, 2016
Proposal for a simple pneumonia diagnostic tool meant to address epidemic in developing countries. March 22, 2015, 10:30 am The RespiDx team (Ian Solomon is second from right). Email The RespiDx team (Ian Solomon is second from right). Last month, ISRAEL21c reported that two Israeli startups – RespiDX and NanoVation GS — won seed grants from Grand Challenges Israel for their product ideas for diagnosing childhood pneumonia in low-resource regions. We recently received word from RespiDX that our coverage proved critical in promoting its concept to key organizations and corporations working to reduce childhood deaths from pneumonia in developing countries. “The article ISRAEL21c wrote describing our Respimometer project has been very helpful to us, and was used by Grand Challenges Canada to create connections for us to the relevant UN bodies, UNICEF, and a range of potential industrial partners,” says Ian Solomon, VP business development for the Profile Group of Companies in Jerusalem. “Following this, the company we established for this project, RespiDx Ltd., is already in discussions with several of these bodies, so the article has been most useful.” He adds that ISRAEL21c’s article was the only one circulated to potential partners by Grand Challenges Canada, and that it came to their attention from an outside source. Respimometer is envisioned as a cross between a pacifier and a digital oral thermometer. The mouth stop just under the child’s nose would be embedded with sensors to measure breathing as a way of detecting pneumonia immediately. “We filed a patent and now we’re looking to use the grant to make a prototype and test it against existing means of measuring respiration rate to prove it’s good enough to be out in the market,” Solomon told ISRAEL21c. RespiDX has applied for a Bill & Melinda Gates Foundation grant and is seeking matching funds to run a test project in Africa in order to identify cultural and field conditions that could impact the final design of the reusable product and the training protocol for healthcare workers. “We also made contact with a researcher who has experience running trial projects with community health workers,” says Solomon. “The idea is to simply diagnose and also simply treat children right in their villages.”
Where is RespiDx's headquarters?
RespiDx's headquarters is located at Jerusalem.
What is RespiDx's latest funding round?
RespiDx's latest funding round is Grant - II.
How much did RespiDx raise?
RespiDx raised a total of $150K.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.